Plasma YKL-40 is elevated, defined as higher than the age-adjusted 95th percentile of plasma YKL-40 in healthy subjects, in 57–72% of patients with glioblastoma [81,94], Figure 4. This evidence concerns the gene CHI3L1 and glioblastoma.